In hepatocellular carcinoma (HCC), IL- 6 activates JAK1/PD-L1 phosphorylation at the Y112 site, followed by stimulation of STT3A recruitment and subsequent glycosylation to increase PD-L1 expression. This evidence concerns the gene JAK1 and hepatocellular carcinoma.